Advanced Enzyme Technologies Ltd

NSE: ADVENZYMES · BSE: 540025 · Pharmaceuticals & Biotechnology · 62 announcements

Share price: ₹272.05
Market cap: ₹3,046 Cr
Revenue (annual): ₹745.8 Cr
Net profit (annual): ₹168.7 Cr
P/E (TTM): 18.4×Sector 47.4×
Promoter holding: 43.24%-0.02% QoQ
FII holding: 26.70%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

8 Jul 2026 16:53 IST NSE

Advanced Enzyme Technologies Board Meeting Outcome

Board recommended Rs.1.35/share dividend and director reappointments for AGM. Related party transactions with subsidiary and relative also approved.

Value: ₹1.35 Cr

Read the filing ↗

9 May 2026 15:40 IST NSE

Board Meeting Outcome

Advanced Enzyme Technologies Board Meeting Outcome

Advanced Enzyme Technologies approved the re-appointment of Executive Director Mukund Kabra and Statutory Auditors. Additionally, Pradip Shah was appointed as an Independent Director for five years.

Execution: 60 months

Read the filing ↗